Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the page-views-count domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/vhosts/indiansat.uk/httpdocs/wp-includes/functions.php on line 6121

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wpdiscuz domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/vhosts/indiansat.uk/httpdocs/wp-includes/functions.php on line 6121

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the gdlr_translate domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/vhosts/indiansat.uk/httpdocs/wp-includes/functions.php on line 6121
UK study: Delta+ responds to jabs available in India – Indians at UK
Home > Covid > UK study: Delta+ responds to jabs available in India

UK study: Delta+ responds to jabs available in India

delta-plus-variant

The vaccines currently available in India have been found to work against the Delta-plus Covid variant, says a UK public health body report. While the Delta variant (B.1.617.2) has already responded to vaccines including Covishield, health experts were concerned about the Delta-plus (B.1.617.2.1) or AY.1. This variant does not respond to monoclonal antibodies cocktail.

According to the latest report of Public Health England (PHE), “Very preliminary results for live virus neutralisation of AY.1 (a lineage of Delta with K417N), with a small number of sera from vaccine recipients are reassuring.” The PHE had obtained the vaccine data from the Genotype-to-Phenotype National Virology Consortium. Of the 161 genomes of Delta-plus uploaded on GISAID till June 22, eight are from India.

Loading

You may also like
AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots
JN.1 Covid variant: WHO charts its rapid global spread
Rishi Sunak faces Covid inquiry and Rwanda vote in key week
travel-panic
Canada, US Leading Study Destinations For Indians, UK Overtakes Australia
0 0 votes
Article Rating
Subscribe
Notify of
guest


0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x